Loading candles…
Influx Healthtech Limited, incorporated in September 2020, is a contract manufacturing company focused on the healthcare sector. The company offers end-to-end services including formulation, packaging, and contract development and manufacturing organization (CDMO) services. Its product range covers nutraceuticals, cosmetics, ayurvedic products, and veterinary products. Influx Healthtech operates multiple manufacturing facilities designed to comply with international standards such as WHO-GMP and ISO certifications. The company serves various industries including healthcare, nutraceuticals, cosmetics, ayurvedic, and veterinary. No information about founders, key management, geographic presence, subsidiaries, or stock listings is available.
This page is a live market overview for INFLUX HEALTHTECH LIMITED (INFLUX) on the NSE. As a listed security, INFLUX HEALTHTECH LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for INFLUX before placing trades on tick2trade.
As of the latest feed, INFLUX last traded at ₹283 on NSE, up ₹7.55 (2.74%) from the previous close of ₹275.45. Today's session range is ₹275.6 – ₹283, against a 52-week band of ₹160.6 – ₹315. Traded volume today stands at 10.20K shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, upcoming corporate events for INFLUX in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether INFLUX is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for INFLUX HEALTHTECH LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in INFLUX. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated INFLUX option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Index Review | NSE indices rebalancing | 31 Mar 2026 |
| Expiry | Monthly F&O expiry | 30 Jan 2026 |
| Expiry | Monthly F&O expiry | 27 Feb 2026 |
| Holiday | Republic Day — market closed | 26 Jan 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.